Wearable Injectors Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Wearable Injectors Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Wearable Injectors Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global wearable
  injectors market size reached US 7.7 Billion in
  2023.
• Wearable injectors (WIs) or patch pumps are drug
  delivery devices utilized for the single-step
  administration of medicines for longer durations.
  They automatically deliver preset doses to
  patients at optimal times. They are temporarily
  attached to the skin to deliver viscous drugs in
  large volumes faster and safely through the
  subcutaneous tissues in the body.
• They comprise a cannula for substance delivery to
  tissues, a reservoir to store medicine, and a
  drive system to provide the appropriate drug
  volume. In addition, these devices are
  user-friendly, disposable, and cause minimal
  discomfort and pain compared to traditionally
  used syringes and vials. As a result, wearable
  injectors are extensively used for the treatment
  of diabetes, rheumatoid arthritis, cancer, and
  cardiovascular diseases.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/wearable-injectors-mark
  et/requestsample

4
Report Description

• Global Wearable Injectors Market Trends
• The market is primarily driven by the increasing
  prevalence of chronic medical illnesses such as
  neurological, oncological, and autoimmune
  disorders. In addition, the rising geriatric
  population, which is more susceptible to such
  ailments, and the escalating demand for minimally
  invasive (MI) treatment alternatives among the
  patients represent other major growth-inducing
  factors. Moreover, the sudden outbreak of the
  coronavirus disease (COVID-19) pandemic prompted
  the entire healthcare system to switch to
  home-based therapies to stop the spread of the
  sickness. This, coupled with the growing
  popularity of at-home and self-administrable
  injectors to effectively manage disorders with
  the minutest risks of inaccurate dosage and
  needle stick injuries, is providing a positive
  thrust to the market growth. Besides this,
  various product innovations, such as the
  incorporation of wireless connectivity, passive
  warning systems, and Bluetooth technologies with
  the injectors, are anticipated to propel the
  market growth. These technologies promote
  convenient monitoring of the patient through a
  smartphone application and offer timely reminders
  for dosages. Furthermore, extensive research and
  development (RD) activities, along with
  significant improvements in the healthcare
  infrastructure, are creating a positive market
  outlook.
• Looking forward, IMARC Group expects the market
  value to reach US 24.4 Billion by 2032,
  exhibiting a CAGR of 13.4 during the forecast
  period (2024-2032).
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/wearable-injectors-mark
  et

5
Report Segmentation

• Breakup by Type
• On-body
• Off-body
•  
• Breakup by Technology
• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others
• Breakup by Application
• Oncology
• Infectious Diseases
• Cardiovascular Diseases

6
Report Segmentation

• Autoimmune Diseases
• Others
• Breakup by End Use
• Hospitals and Clinics
• Home Care
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Becton Dickinson and Company
• CeQur SA
• Debiotech SA
• Dexcom Inc.
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corporation
• Tandem Diabetes Care Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Wearable Injectors
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type
• 6.1 On-body
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Off-body
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Technology
• 7.1 Spring-based
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

11
Table of Contents

• 7.2 Motor-driven
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Rotary Pump
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Expanding Battery
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 7.5 Others
• 7.5.1 Market Trends
• 7.5.2 Market Forecast
• 8 Market Breakup by Application
• 8.1 Oncology
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Infectious Diseases
• 8.2.1 Market Trends
• 8.2.2 Market Forecast

12
Partial List of Clients
13
Partial List of Clients
14
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us